Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 9:10:883453.
doi: 10.3389/fpubh.2022.883453. eCollection 2022.

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China

Songjie Wu  1   2 , Fangzhao Ming  3 , Zhongyuan Xing  4 , Zhiyue Zhang  4 , Shanhui Zhu  5 , Wei Guo  6   7 , Shi Zou  8 , Jinli Liu  8 , Yang Liu  9   10 , Ke Liang  1   2   8   11
Affiliations

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China

Songjie Wu et al. Front Public Health. .

Abstract

Vaccination is essential to controlling the pandemic of coronavirus disease 2019 (COVID-19). People living with HIV (PLWH) were considered more vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with the general population. Therefore, it is urgent to protect PLWH from SARS-CoV-2 infection. For PLWH, vaccine hesitancy could be more common and may compromise vaccine coverage. Our study aimed to investigate the willingness to receive the COVID-19 vaccination among PLWH and associated factors. A cross-sectional online survey was performed among PLWH and the general population from 4 April to 18 April 2021 in Wuhan, China. The multivariable logistic regression was used to analyze associated factors for COVID-19 vaccination willingness among PLWH. A total of 556 PLWH and 570 individuals from the general population were enrolled. The COVID-19 vaccine willingness among PLWH was 60.8%, which was relatively lower than that in the general population (80.9%) (P < 0.001). The results of multivariable analysis indicated that PLWH with comorbidities (OR = 2.07, 95% CI: 1.25-3.45), those who had idea about PLWH would be more serious if they were infected with SARS-CoV-2 (OR = 1.67, 95% CI: 1.11-2.51) and those who thought their antiretroviral therapy (ART) would be affected by COVID-19 epidemic (OR = 2.04, 95% CI: 1.22-3.42) had higher willingness to receive COVID-19 vaccination. PLWH who had a monthly income over 5,000 RMB (OR = 0.64, 95% CI: 0.45-0.92) and had a sex orientation as non-homosexual (OR = 0.67, 95% CI: 0.47-0.96) were associated with lower willingness for COVID-19 vaccination. Our findings showed that the PLWH had a lower willingness for COVID-19 vaccination compared with the general population in Wuhan. Targeted interventions such as health education should be conducted to increase the willingness for COVID-19 vaccination among PLWH, thus enhancing COVID-19 vaccine uptake among PLWH.

Keywords: COVID-19 vaccination; PLWH; Wuhan; general population; willingness.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
COVID-19 vaccination willingness among PLWH (60.8%) is significantly lower than the general population (80.9%), P < 0.001, multivariable logistic regression model was used.
Figure 2
Figure 2
Proportion of reasons for willingness and unwillingness to receive COVID-19 vaccination among PLWH.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization . Coronavirus Disease 2019 (COVID-19). Numbers at a Glance. Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed February 22, 2022).
    1. Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. . Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. (2021) 11:6283. 10.1038/s41598-021-85359-3 - DOI - PMC - PubMed
    1. Venturas J, Zamparini J, Shaddock E, Stacey S, Murray L, Richards GA, et al. . Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19. J Infect. (2021) 83:217–27. 10.1016/j.jinf.2021.05.020 - DOI - PMC - PubMed
    1. Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. . HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. (2021) 8:e24–32. 10.1016/S2352-3018(20)30305-2 - DOI - PMC - PubMed
    1. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of COVID-19 in people living with HIV: a syndemic perspective. AIDS Behav. (2020) 24:2244–9. 10.1007/s10461-020-02871-9 - DOI - PMC - PubMed

Publication types

Substances